SLC11A2 and prostate carcinoma: Using TNMplot, an integrated database of available transcriptome-level datasets enabling the comparison of normal, tumor, and metastatic data across all genes [56], we observed that DMT1 gene expression was significantly decreased in metastatic tissue compared to primary tumor in breast cancer patient samples as well as in esophageal and prostate cancer.